Publication | Closed Access

Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)

Autoimmune DiseasePhase IiiClinical TrialsClinical DermatologySkin PharmacologyKorean PatientsDermatologyExperimental DermatologyMedicineModerate-to-severe Psoriasis